Identification and Characterization of a Vancomycin Intermediate-Resistant Staphylococcus haemolyticus Isolated from

Wanyang Dong1, Qi Peng1, Xiaohua Tang1,2

  • 1Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, 510180, People's Republic of China.

PubMed
Abstract

Insights

This study identifies vancomycin intermediate-resistance in Staphylococcus haemolyticus SH-1, linked to specific WalKR mutations. These findings offer insights into the molecular mechanisms driving resistance in this opportunistic pathogen.

Area of Science:

  • Microbiology
  • Genomics
  • Molecular Biology

Background:

  • Staphylococcus haemolyticus is an opportunistic pathogen within the coagulase-negative Staphylococci group.
  • Increasing infections and multi-drug resistance cases highlight its significant public health threat.

Purpose of the Study:

  • To analyze drug resistance genes, including vancomycin resistance, in a clinical S. haemolyticus isolate.
  • To investigate the biological characteristics associated with vancomycin intermediate-resistance.

Main Methods:

  • Third-generation sequencing for genome analysis.
  • Antimicrobial susceptibility testing.
  • Transmission electron microscopy and autolysis assays.

Main Results:

  • The S. haemolyticus SH-1 isolate demonstrated vancomycin intermediate-resistance.
  • WalK(N70K) and WalK(R280Q) mutations were identified and may contribute to vancomycin resistance.
  • The strain exhibited a thicker cell wall and reduced autolytic activity.

Conclusions:

  • WalKR mutations in S. haemolyticus SH-1 correlate with vancomycin resistance characteristics.
  • The study provides valuable information on the molecular mechanisms of vancomycin intermediate-resistance in S. haemolyticus.